Research Brief: Glowing Glia Mark Disease Progression in AD Mice
conference story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2683 Alzheimer's
379 RESULTS
You searched Esther
Sort By:
conference story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2683 Alzheimer's
said. “But at least people felt there was good reason to pay attention to that interface.”—Esther
hypothesis bears out.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2988 Alzheimer's
Alzforum.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3235 Alzheimer's Disease Amyloid
hypothesis,” Chapuis suggested in an e-mail to Alzforum.—Esther Landhuis. None
imaging, as none of the six patients with AD-like features in this study had severe dementia.—Esther
series.—Esther Landhuis This is Part 1 of a two-part series. See also Part 2. None
take one baby step toward more complex genetics and try to find modifier genes,” he said.—Esther
astrocytic/neuronal cell culture model used in their SfN research, Sadowski told ARF.—Esther Landhuis. This is Part
neurons with blocked lysosomal proteolysis.—Esther Landhuis None
proteins—could still mediate key APP functions.—Esther Landhuis. None
control antibodies to tubulin, were able to block QDAβ aggregation.—Esther Landhuis None
impairment (see ARF related news story).—Esther Landhuis. This is Part 2 of a two-part story. See Part 1.
in an e-mail to ARF.—Esther Landhuis This is Part 3 of a three-part series. See also Part 1 and Part
inhibitors.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3339 Alzheimer's Disease Biomarkers